Document Detail


Successful treatment of chronic esophageal moniliasis with a viscous suspension of nystatin.
MedLine Citation:
PMID:  5212385     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A 35-year-old man with idiopathic hypoparathyroidism and moniliasis developed progressive dysphagia and weight loss. Diagnostic studies established the presence of esophageal moniliasis. Therapy with a viscous suspension of nystatin resulted in rapid clinical improvement; prolonged administration of the drug was associated with progressive widening of a narrowed segment of esophagus and complete disappearance of dysphagia. The chemotherapy of esophageal moniliasis is discussed in the light of current knowledge of the pharmacological action of nystatin.
Authors:
P A Kantrowitz; D J Fleischli; W T Butler
Related Documents :
15507865 - Reviewing the mechanism of action of thiopurine drugs: towards a new paradigm in clinic...
18306275 - Intra-articular depot formulation principles: role in the management of postoperative p...
25486495 - Haemonchus contortus p-glycoprotein-2: in situ localization and characterization of mac...
17462275 - From frown lines to fissures: therapeutic uses for botulinum toxin.
1200845 - Comparison of the ability of small molecular interferon inducers: tilorone and acridine...
22323035 - A case of severe hypokalemia caused by a chinese herbal remedy (yokukansan) in an 81-ye...
Publication Detail:
Type:  Case Reports; Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Gastroenterology     Volume:  57     ISSN:  0016-5085     ISO Abbreviation:  Gastroenterology     Publication Date:  1969 Oct 
Date Detail:
Created Date:  1986-10-30     Completed Date:  1986-10-30     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0374630     Medline TA:  Gastroenterology     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  424-30     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Adult
Candidiasis / drug therapy*
Chronic Disease
Deglutition Disorders / etiology
Esophageal Diseases / drug therapy*
Esophagus / physiopathology,  radiography
Humans
Male
Nystatin / administration & dosage*
Suspensions
Viscosity
Grant Support
ID/Acronym/Agency:
T1-AM-5146/AM/NIADDK NIH HHS
Chemical
Reg. No./Substance:
0/Suspensions; 1400-61-9/Nystatin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A new method for evaluation of portasystemic shunting. The rectal octanoate tolerance test.
Next Document:  Detection of individual susceptibility toward coronary disease.